Biocide use and antibiotic resistance: the relevance of laboratory findings to clinical and environmental situations

被引:306
作者
Russell, AD [1 ]
机构
[1] Cardiff Univ, Welsh Sch Pharm, Cardiff CF1 3XF, S Glam, Wales
关键词
D O I
10.1016/S1473-3099(03)00833-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Antibiotics are used as chemotherapeutic drugs, and biocides are used as antiseptics, disinfectants, and preservatives. Several factors affect biocidal activity, notably concentration, period of contact, pH, temperature, the presence of interfering material, and the types, numbers, location, and condition of microorganisms. Bacterial cells as part of natural or artificial (laboratory) biofilm communities are much less susceptible than planktonic cells to antibiotics and biocides. Assessment of biocidal activity by bactericidal testing is more relevant than by determination of minimum inhibitory concentrations. Biocides and antibiotics may show some similarities in their mechanisms of action and common mechanisms of bacterial insusceptibility may apply, but there are also major differences. In the laboratory, bacteria can become less susceptible to some biocides. Decreased resistance may be stable or unstable and may be accompanied by a low-level increase in antibiotic resistance. Laboratory studies are useful for examining stress responses and basic mechanisms of action and of bacterial insusceptibility to antibacterial agents. Translation of such findings to the clinical and environmental situations to provide evidence of a possible relation between biocide use and clinical antibiotic resistance is difficult and should be viewed with caution.
引用
收藏
页码:794 / 803
页数:10
相关论文
共 129 条
[1]   Increase in resistance of methicillin-resistant Staphylococcus aureus to β-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals [J].
Akimitsu, N ;
Hamamoto, H ;
Inoue, R ;
Shoji, M ;
Akamine, A ;
Takemori, K ;
Hamasaki, N ;
Sekimizu, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (12) :3042-3043
[2]   Susceptibility of MRSA to triclosan [J].
Al-Doori, Z ;
Morrison, D ;
Edwards, G ;
Gemmell, C .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) :185-185
[3]   The development of the BSAC standardized method of disc diffusion testing [J].
Andrews, JM .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 :29-42
[4]  
[Anonymous], 1999, An Introduction to genetic analysis
[5]   Organization of the antiseptic resistance gene qacA and Tn552-related β-lactamase genes in multidrug-resistant Staphylococcus haemolyticus strains of animal and human origins [J].
Anthonisen, IL ;
Sunde, M ;
Steinum, TM ;
Sidhu, MS ;
Sorum, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (11) :3606-3612
[6]   An assessment of triclosan susceptibility in methicillin-resistant and methicillin-sensitive Staphylococcus aureus [J].
Bamber, AI ;
Neal, TJ .
JOURNAL OF HOSPITAL INFECTION, 1999, 41 (02) :107-109
[7]   INHA, A GENE ENCODING A TARGET FOR ISONIAZID AND ETHIONAMIDE IN MYCOBACTERIUM-TUBERCULOSIS [J].
BANERJEE, A ;
DUBNAU, E ;
QUEMARD, A ;
BALASUBRAMANIAN, V ;
UM, KS ;
WILSON, T ;
COLLINS, D ;
DELISLE, G ;
JACOBS, WR .
SCIENCE, 1994, 263 (5144) :227-230
[8]   LABORATORY AND INVITRO TESTING OF SKIN ANTISEPTICS - A PREDICTION FOR INVIVO ACTIVITY [J].
BAQUERO, F ;
PATRON, C ;
CANTON, R ;
FERRER, MM .
JOURNAL OF HOSPITAL INFECTION, 1991, 18 :5-11
[9]  
BAQUERO F, 1998, CLIN INFECT DIS S1, V27, P5
[10]   Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary clinical isolates of Pseudomonas aeruginosa [J].
Beinlich, KL ;
Chuanchuen, R ;
Schweizer, HP .
FEMS MICROBIOLOGY LETTERS, 2001, 198 (02) :129-134